津普森 |
B110665-1mg |
1mg |
现货 |
1227911-45-6 |
(3S,6R)-1-(6-(3-氨基-1H-吲唑-6-基... |
98%,B |
98.00
98.00
|
|
津普森 |
B110665-5mg |
5mg |
现货 |
1227911-45-6 |
(3S,6R)-1-(6-(3-氨基-1H-吲唑-6-基... |
98%,B |
293.30
293.30
|
|
罗恩 |
R028188-5mg |
5mg |
现货 |
1227911-45-6 |
(3S,6R)-1-[6-(3-氨基-1H-吲唑-6-基... (3S,6R)-1-[6-(3-amino-1H-ind... |
98% |
317.00
317.00
|
|
Selleck |
S708710mg |
10mg |
现货 |
1227911-45-6 |
GSK2334470 |
|
1,181.72
1,181.72
|
|
Selleck |
S708750mg |
50mg |
现货 |
1227911-45-6 |
GSK2334470 |
|
3,836.13
3,836.13
|
|
毕得 |
BD630021-1mg |
1mg |
现货 |
1227911-45-6 |
(3S,6R)-1-(6-(3-氨基-1H-吲唑-6-基... (3S,6R)-1-(6-(3-Amino-1H-ind... |
99% |
142.00
142.00
|
|
毕得 |
BD630021-5mg |
5mg |
现货 |
1227911-45-6 |
(3S,6R)-1-(6-(3-氨基-1H-吲唑-6-基... (3S,6R)-1-(6-(3-Amino-1H-ind... |
99% |
425.00
425.00
|
|
阿拉丁 |
G126481-10mg |
10mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
622.90
622.90
|
|
阿拉丁 |
G126481-50mg |
50mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
2,247.90
2,247.90
|
|
阿拉丁 |
G126481-5mg |
5mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
352.90
352.90
|
|
阿拉丁 |
G409142-1ml |
1ml |
现货 |
1227911-45-6 |
GSK2334470 GSK2334470 |
Moligand™, 10mM in DMSO |
960.90
960.90
|
|
阿拉丁 |
G126481-100mg |
100mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
4,099.90
4,099.90
|
|
阿拉丁 |
G126481-200mg |
200mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
6,699.90
6,699.90
|
|
阿拉丁 |
G126481-25mg |
25mg |
现货 |
1227911-45-6 |
GSK2334470,新型有效的PDK1抑制剂 GSK2334470 |
Moligand™, ≥95% |
1,322.90
1,322.90
|
|
麦克林 |
G872477-5mg |
5mg |
现货 |
1227911-45-6 |
GSK2334470 GSK2334470 |
99% |
367.00
367.00
|
|